rewirebio.iobenchmarks
Evaluation

FRASER (2021 article implementation) evaluation

FRASER (2021 article implementation) evaluation; bounded primary-source AMP candidate.

Evaluation results

1 evaluation · 2 results. Different protocols are not a single leaderboard.

Protocol: FRASER Kremer cohort known pathogenic-event subsampling · Dataset: Kremer rare mitochondrial-disorder skin-fibroblast RNA cohort

Sorted by Recall (30 samples, mean) (higher is better). The best value in each column is highlighted. Decimals are rounded for display; each value links to the printed value and its source.

Tested configurationRecall (30 samples, mean)True positives (30 samples, mean)
FRASER (2021 article implementation)Evaluation85%11
All 2 result rows with coverage, uncertainty and sources
Filter evaluations

Applied filters: All linked evaluations

Exact evaluated configurations and original reported results
Tested configurationProtocol and datasetFindingEvidence and details
Configuration: FRASER (2021 article implementation)Protocol: FRASER Kremer cohort known pathogenic-event subsampling
Dataset: Kremer rare mitochondrial-disorder skin-fibroblast RNA cohort
85% Recall (30 samples, mean)
percent · higher

Uncertainty: Not yet extracted

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

FRASER (2021 article implementation) evaluation

Randomly remove samples without known pathogenic splicing defect; measure fraction of 13 known events recovered at reduced cohort size. At 30 samples, 85% / mean 11 of 13; 100 samples needed to recover all irrespective of selected samples. FRASER controls latent confounding and models beta-binomial count fractions; cohort analysis uses FDR<0.1 and |effect|>0.3.

Aggregation: Not reported

Detection of aberrant splicing events in RNA-seq data using FRASER · Results subsection rare disease cohort, paragraph Par18; Supplementary Fig. S20 referenced
Configuration: FRASER (2021 article implementation)Protocol: FRASER Kremer cohort known pathogenic-event subsampling
Dataset: Kremer rare mitochondrial-disorder skin-fibroblast RNA cohort
11 True positives (30 samples, mean)
count · higher

Uncertainty: Not yet extracted

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

FRASER (2021 article implementation) evaluation

Randomly remove samples without known pathogenic splicing defect; measure fraction of 13 known events recovered at reduced cohort size. At 30 samples, 85% / mean 11 of 13; 100 samples needed to recover all irrespective of selected samples. FRASER controls latent confounding and models beta-binomial count fractions; cohort analysis uses FDR<0.1 and |effect|>0.3.

Aggregation: Not reported

Detection of aberrant splicing events in RNA-seq data using FRASER · Results Par18; Supplementary Fig. S20 referenced

Source checking is not independent reproduction. Release 2026-11-21-c8bea25e5abb.

Research readiness

0 of 4 readiness checks met. These checks assess whether the evidence supports a reproducible investigation; a source-checked score alone does not meet them.

Readiness checks, gaps and artifacts

Release 2026-11-21-c8bea25e5abb · Evidence verified: Not verified

Evidence incomplete

Replay metrics

Exact outcomes, predictions, identifiers and evaluator are connected.

Missing or unresolved evidence

  • No verified artifact manifest is linked to this exact record.
  • File checksums match the recorded files: not yet verified
  • Predictions are matched to the right samples: not yet verified
  • Score meaning and direction are confirmed: not yet verified
  • Metrics are recomputed from the saved predictions: not yet verified

Verified: Not verified

Evidence incomplete

Investigate discrepancies

Replay evidence includes annotations and an assessment of dependence. Unknown independence permits descriptive analysis only.

Missing or unresolved evidence

  • No verified artifact manifest is linked to this exact record.
  • File checksums match the recorded files: not yet verified
  • Predictions are matched to the right samples: not yet verified
  • Score meaning and direction are confirmed: not yet verified
  • Metrics are recomputed from the saved predictions: not yet verified
  • Sample annotations are recorded: not yet verified
  • Dependence between samples is assessed: not yet verified

Verified: Not verified

Evidence incomplete

Run locally

A pinned recipe describes the inputs, environment and resource requirements.

Missing or unresolved evidence

  • No verified artifact manifest is linked to this exact record.
  • File checksums match the recorded files: not yet verified
  • Predictions are matched to the right samples: not yet verified
  • Score meaning and direction are confirmed: not yet verified
  • A pinned run recipe exists: not yet verified
  • Compute requirements are estimated: not yet verified

Verified: Not verified

Evidence incomplete

Validate independently

Separate data and exposure records support an independent test.

Missing or unresolved evidence

  • No verified artifact manifest is linked to this exact record.
  • File checksums match the recorded files: not yet verified
  • Predictions are matched to the right samples: not yet verified
  • Score meaning and direction are confirmed: not yet verified
  • Independent validation data exist: not yet verified
  • Overlap with training data is checked: not yet verified

Verified: Not verified

Readiness describes the evidence in this release. Availability on your computer is checked separately when an investigation runs. Existing data exposure can prevent independent validation even when files are available.

Artifacts and reproduction

No verified artifact manifest is connected to this record yet. The gaps above identify what is needed before analysis can begin.

Evaluation procedure

Randomly remove samples without known pathogenic splicing defect; measure fraction of 13 known events recovered at reduced cohort size. At 30 samples, 85% / mean 11 of 13; 100 samples needed to recover all irrespective of selected samples. FRASER controls latent confounding and models beta-binomial count fractions; cohort analysis uses FDR<0.1 and |effect|>0.3.

Configuration
FRASER (2021 article implementation)
Protocol
FRASER Kremer cohort known pathogenic-event subsampling
Dataset
Kremer rare mitochondrial-disorder skin-fibroblast RNA cohort
origin
Author-reported evaluation
configuration
Not reported
adaptation
Not reported
aggregation
average across sample selections; number of selections unextracted
budget
Not reported
dataset version
Not reported
inputs
patient skin-fibroblast RNA aligned BAM
metric implementation
Not reported
population
13 known events within 119 samples/105 individuals
protocol id
Not reported
split
retrospective sample-size subsampling

Metadata review: source checked. Unreported conditions prevent automatic comparisons.

Reproduction

Split
retrospective sample-size subsampling
Adaptation
Not reported
Scoring implementation
Not reported

No execution recipe has been verified for this exact configuration and evaluation. A benchmark's general instructions may use different inputs, splits or model settings.

Reproducing this published result requires matching its model configuration, data, split and scorer. Source checking or a successful smoke test does not establish score reproduction.

Evidence

Source checking verifies the cited claim or transcription. It does not establish independent reproduction.

Evidence table

Inspect claims, sources and review details

Trace each statement to its source and review. A context-only reference supports the record generally; it does not verify an individual field. Source checking does not reproduce an experiment.

One row per statement and cited source. Multiple citations are not independent evaluations. Shared locators are labelled explicitly.

16 evidence rows matching the loaded filters

Claims, original sources and review scope · Release 2026-11-21-c8bea25e5abb
Property and statementOriginal source and locationReview and provenance
Comparison: adaptation
Not reported
Context-only references
Detection of aberrant splicing events in RNA-seq data using FRASER

Original source ↗

No field-specific location recorded

Version: Europe PMC fullTextXML retrieved 2026-10-07T12:23:57.289375+00:00
Retrieved: 2026-10-07T12:23:57.289375+00:00

missing or unspecified

No individual claim review recorded

author reported

Audit details

Field: attributes.comparison.adaptation

Source artifact SHA-256: 1f1f028cddd9145bd342422ec768ecdca6ecfeb6f9bc2e114ecfab061b5e93a6

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Comparison: aggregation
average across sample selections; number of selections unextracted
Context-only references
Detection of aberrant splicing events in RNA-seq data using FRASER

Original source ↗

No field-specific location recorded

Version: Europe PMC fullTextXML retrieved 2026-10-07T12:23:57.289375+00:00
Retrieved: 2026-10-07T12:23:57.289375+00:00

not individually reviewed

No individual claim review recorded

author reported

Audit details

Field: attributes.comparison.aggregation

Source artifact SHA-256: 1f1f028cddd9145bd342422ec768ecdca6ecfeb6f9bc2e114ecfab061b5e93a6

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Comparison: budget
Not reported
Context-only references
Detection of aberrant splicing events in RNA-seq data using FRASER

Original source ↗

No field-specific location recorded

Version: Europe PMC fullTextXML retrieved 2026-10-07T12:23:57.289375+00:00
Retrieved: 2026-10-07T12:23:57.289375+00:00

missing or unspecified

No individual claim review recorded

author reported

Audit details

Field: attributes.comparison.budget

Source artifact SHA-256: 1f1f028cddd9145bd342422ec768ecdca6ecfeb6f9bc2e114ecfab061b5e93a6

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Comparison: dataset version
Not reported
Context-only references
Detection of aberrant splicing events in RNA-seq data using FRASER

Original source ↗

No field-specific location recorded

Version: Europe PMC fullTextXML retrieved 2026-10-07T12:23:57.289375+00:00
Retrieved: 2026-10-07T12:23:57.289375+00:00

missing or unspecified

No individual claim review recorded

author reported

Audit details

Field: attributes.comparison.dataset_version

Source artifact SHA-256: 1f1f028cddd9145bd342422ec768ecdca6ecfeb6f9bc2e114ecfab061b5e93a6

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Comparison: inputs
patient skin-fibroblast RNA aligned BAM
Context-only references
Detection of aberrant splicing events in RNA-seq data using FRASER

Original source ↗

No field-specific location recorded

Version: Europe PMC fullTextXML retrieved 2026-10-07T12:23:57.289375+00:00
Retrieved: 2026-10-07T12:23:57.289375+00:00

not individually reviewed

No individual claim review recorded

author reported

Audit details

Field: attributes.comparison.inputs

Source artifact SHA-256: 1f1f028cddd9145bd342422ec768ecdca6ecfeb6f9bc2e114ecfab061b5e93a6

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Comparison: metric implementation
Not reported
Context-only references
Detection of aberrant splicing events in RNA-seq data using FRASER

Original source ↗

No field-specific location recorded

Version: Europe PMC fullTextXML retrieved 2026-10-07T12:23:57.289375+00:00
Retrieved: 2026-10-07T12:23:57.289375+00:00

missing or unspecified

No individual claim review recorded

author reported

Audit details

Field: attributes.comparison.metric_implementation

Source artifact SHA-256: 1f1f028cddd9145bd342422ec768ecdca6ecfeb6f9bc2e114ecfab061b5e93a6

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Comparison: population
13 known events within 119 samples/105 individuals
Context-only references
Detection of aberrant splicing events in RNA-seq data using FRASER

Original source ↗

No field-specific location recorded

Version: Europe PMC fullTextXML retrieved 2026-10-07T12:23:57.289375+00:00
Retrieved: 2026-10-07T12:23:57.289375+00:00

not individually reviewed

No individual claim review recorded

author reported

Audit details

Field: attributes.comparison.population

Source artifact SHA-256: 1f1f028cddd9145bd342422ec768ecdca6ecfeb6f9bc2e114ecfab061b5e93a6

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Comparison: protocol id
Not reported
Context-only references
Detection of aberrant splicing events in RNA-seq data using FRASER

Original source ↗

No field-specific location recorded

Version: Europe PMC fullTextXML retrieved 2026-10-07T12:23:57.289375+00:00
Retrieved: 2026-10-07T12:23:57.289375+00:00

missing or unspecified

No individual claim review recorded

author reported

Audit details

Field: attributes.comparison.protocol_id

Source artifact SHA-256: 1f1f028cddd9145bd342422ec768ecdca6ecfeb6f9bc2e114ecfab061b5e93a6

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Comparison: split
retrospective sample-size subsampling
Context-only references
Detection of aberrant splicing events in RNA-seq data using FRASER

Original source ↗

No field-specific location recorded

Version: Europe PMC fullTextXML retrieved 2026-10-07T12:23:57.289375+00:00
Retrieved: 2026-10-07T12:23:57.289375+00:00

not individually reviewed

No individual claim review recorded

author reported

Audit details

Field: attributes.comparison.split

Source artifact SHA-256: 1f1f028cddd9145bd342422ec768ecdca6ecfeb6f9bc2e114ecfab061b5e93a6

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Origin
author_reported
Context-only references
Detection of aberrant splicing events in RNA-seq data using FRASER

Original source ↗

No field-specific location recorded

Version: Europe PMC fullTextXML retrieved 2026-10-07T12:23:57.289375+00:00
Retrieved: 2026-10-07T12:23:57.289375+00:00

not individually reviewed

No individual claim review recorded

author reported

Audit details

Field: attributes.origin

Source artifact SHA-256: 1f1f028cddd9145bd342422ec768ecdca6ecfeb6f9bc2e114ecfab061b5e93a6

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

How to read the evidence

Sources and history

Release 2026-11-21-c8bea25e5abb · Record review: source checked

1 source record and release historyDownload this release (gzip)
Technical metadata and extraction receipts

Stable ID: amp-oncology-rna-20261007-issue-12-eval-fraser-2021-article-implementation

comparison
adaptation: Not reported; aggregation: average across sample selections; number of selections unextracted; budget: Not reported; dataset version: Not reported; inputs: patient skin-fibroblast RNA aligned BAM; metric implementation: Not reported; population: 13 known events within 119 samples/105 individuals; protocol id: Not reported; split: retrospective sample-size subsampling
missing metadata
replicate count: reason: unextracted; note: Subsampling repetition count unextracted; uncertainty: reason: unavailable; note: No numeric CI for 85% printed in Par18; supplement inaccessible; version: reason: unextracted; note: Exact FRASER package version unextracted; do not assign current FRASER2.0
origin
author_reported
protocol
Randomly remove samples without known pathogenic splicing defect; measure fraction of 13 known events recovered at reduced cohort size. At 30 samples, 85% / mean 11 of 13; 100 samples needed to recover all irrespective of selected samples. FRASER controls latent confounding and models beta-binomial count fractions; cohort analysis uses FDR<0.1 and |effect|>0.3.
Related records

Suggest a correction